Bioinformatics Consulting & Design
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
30
NCT05533892
Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCC
Phase: Phase 1
Role: Collaborator
Start: Sep 1, 2022
Completion: Feb 28, 2025
Loading map...